DDI’s team, from both Research and Medical Sectors, participated in the American Diabetes Association’s (ADA) 79th Scientific Sessions held June 7-11, 2019, at the Moscone Center in San Francisco, California.

Dr. Qais Saleh Al-Duwairi, Director General of DDI, Dr. Ebaa Al-Ozairi, Chief Medical Officer, and other researchers and medical staff of the Institute attended the sessions.

The Research Sector team, led by Prof Fahd Al-Mulla, presented six research posters accepted by the conference committee. This is an important achievement in addition to the Institute’s outstanding achievements in the local level. And regional research in the field of leading scientific research. The sessions aim to offer researchers and health care professionals an amazing opportunity to share ideas and learn about the significant advances in diabetes research, treatment, and care.

The research poster presentations included:

  1. Type 2 Diabetes Is Associated with Higher Serum Levels of Circulating Adenylyl Cyclase 8: A Novel Biomarker of the Disease

DDI’s team identifies a possible indicator, measured from the blood, that can determine whether you develop type 2 diabetes.

  1. Oxidative Stress Induces Toll-Like Receptor -2 and -4 in Human Peripheral Blood Mononuclear Cells: Implications for Metabolic Inflammation

By controlling specific immune responses in the body, DDI’s research team identifies a possibility to control the development of diabetes-related diseases in obese individuals and those with type 2 diabetes.

  1. Cross Talk between Palmitate and LPS Leads to a Synergistic IL-6 Production in Human Monocytic Cells: Implications for Metabolic Inflammation

DDI’s team identifies another possible key player of type 2 diabetes development and insulin resistance in obese individuals.

  1. Mir 103/107 Regulates Lipid Metabolism by Inhibiting Betatrophin/ANGPTL8

DDI identifies a possible drug pathway that can prevent insulin resistance and abnormal amounts of fat in people with diabetes.

  1. Investigating the Role of MPO and ANGPTL6 in Obesity and Diabetes and Their Potential Role in Wound Healing

DDI’s team identifies a protein that promotes wound healing and immune response in diabetes and obesity.

  1. Irisin, Meteorin-Like Protein, and Bone Remodeling Markers in T2D and Obesity

DDI’s research team identifies a process to identify and prevent bone related complications in type 2 diabetes.